Search the hub
Showing results for tags 'Medication'.
Found 1,130 results
-
Content Article
MHRA: The Yellow Card Scheme
Claire Cox posted an article in Adverse interactions
The Yellow Card Scheme helps the Medicines and Healthcare products Regulatory Agency (MHRA) monitor the safety of all healthcare products in the UK to ensure they are acceptably safe for patients and those who use them. On the Yellow Card Scheme website you can report a suspected incident or problem. -
Content ArticleThe Institute for Safe Medication Practices (ISMP) is the only US nonprofit organisation devoted entirely to preventing medication errors. In this short video, produced by ISMP in partnership with the Temple University School of Pharmacy, experts discuss current medication safety concerns and offer practical error prevention recommendations.
-
Content ArticleThe Institute for Safe Medication Practices (ISMP) is the only nonprofit organisation in the US devoted entirely to preventing medication errors. In this video, produced by ISMP in partnership with the Temple University School of Pharmacy, experts discuss medication safety concerns and offer practical error prevention recommendations.
-
Content ArticleGuidance from the National Institute for Health and Care Excellence (NICE) cites evidence that when people move from one care setting to another, between 30% and 70% of patients have an error or unintentional change to their medicines. This presents a significant risk to their safety. Maintaining safe care as patients move across health and care services is a national priority for the NHS.
-
Content ArticleThe US Institute for Safe Medication Practices (ISMP) is the only nonprofit organisation devoted entirely to preventing medication errors. During its more than 30-year history, ISMP has helped make a difference in the lives of millions of patients and the healthcare professionals who care for them. ISMP is known and respected as the gold standard for medication safety information. It also has served as a vital force for progress. ISMP’s advocacy work alone has resulted in numerous necessary changes in clinical practice, public policy, and drug labelling and packaging.
-
Content ArticleThe Health Information and Quality Authority (HIQA) is an independent authority established to drive high-quality and safe care for people using our health and social care services in Ireland. HIQA’s mandate to date extends across a specified range of public, private and voluntary sector services. Reporting to the Minister for Health and engaging with the Minister for Children and Youth Affairs, HIQA’s role is to develop standards, inspect and review health and social care services and support informed decisions on how services are delivered.
-
Content ArticleThis professional guidance has been co-produced by the Royal Pharmaceutical Society (RPS) and Royal College of Nursing (RCN) and provides principles-based guidance to ensure the safe administration of medicines by healthcare professionals.
-
Content ArticleGetting the most from medicines for both patients and the NHS is becoming increasingly important as more people are taking more medicines. Medicines prevent, treat or manage many illnesses or conditions and are the most common intervention in healthcare. However, it has been estimated that between 30% and 50% of medicines prescribed for long-term conditions are not taken as intended.
-
Content ArticleThere are an estimated 200,000 severe adverse drug errors (ADRs) in Canada each year, though it is estimated that 95% of ADRs are not reported. They cost the Canadian healthcare system between $13.7 and $17.7 billion each year and kill up to 22,000 Canadians each year. Over 5,000 of these are Canadian children. ADR Canada is working to prevent this. This article explains the role of genomics in the solution to adverse drug reactions.
-
Content Article
Bottle of Lies by Katherine Eban
Patient Safety Learning posted an article in Recommended books and literature
The troubles of Indian pharma companies abroad raise questions about the domestic drug regulator. Although Bottle of Lies, a book about the quality problems plaguing generic drugs, focuses on medicines intended for American consumers, the real and continuing victims of the failings described in the book are consumers in developing countries, including Indians. In May 2013, soon after the erstwhile Ranbaxy Laboratories admitted in an American court to selling adulterated drugs, journalist Katherine Eban published a gripping 10,000-word account of the saga in Fortune magazine. But the story left Eban wondering if Ranbaxy was an isolated case. Could there be more rotten eggs, she asked, given the United States Food & Drugs Administration’s (FDA) lax policing of overseas manufacturers? Bottle of Lies is the result of the multi-year investigation that followed. -
Content ArticleThe Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines, medical devices and blood components for transfusion in the UK. MHRA is an executive agency, sponsored by the Department of Health and Social Care. Recognised globally as an authority in its field, the agency plays a leading role in protecting and improving public health and supports innovation through scientific research and development. The agency has 3 centres: Clinical Practice Research Datalink (CPRD), a data research service that aims to improve public health by using anonymised NHS clinical data the National Institute for Biological Standards and Control (NIBSC), a global leader in the standardisation and control of biological medicines the Medicines and Healthcare products Regulatory Agency (MHRA), the UK’s regulator of medicines, medical devices and blood components for transfusion, responsible for ensuring their safety, quality and effectiveness.
-
Content ArticleThis report from the AHSN Network shines light on ways we can do more to improve safety for residents of care homes. The publication showcases over 30 examples of projects delivered by England’s 15 Patient Safety Collaboratives (PSCs) and the Academic Health Science Networks (AHSNs) which host them. They include case studies in medicines safety, dementia, monitoring and screening, and workforce development.
-
Content Article
Patient Stories: Paul's Story (10 March 2013)
Claire Cox posted an article in Patient stories
In 2007, when Paul Richards was diagnosed with non-Hodgkin lymphoma, his family were stunned by the news. This powerful film from Patient Stories is based on the testimony of Lisa, Paul’s wife, who gives a moving account of the events that led to Paul’s death and explores the effects on their family. -
Content ArticleEffectiveness Matters is a summary of reliable research evidence about the effects of important interventions for practitioners and decision makers in the NHS and public health. It is extensively peer reviewed. This issue focuses on reducing harm from polypharmacy (the use of multiple medicines) in older people.
-
Content ArticleGuidance from the Medicines and Healthcare products Regulatory Agency (MHRA), explains how to package medicines for sale and what information you must provide to consumers and healthcare professionals.
-
Content Article
World Health Organization: Patient engagement (December 2016)
Claire Cox posted an article in Patient engagement
This report is part of a technical series on safer primary care, published by the World Health Organization. The series explores the magnitude and nature of harm in the primary care setting from a number of different angles and provides some possible solutions and practical next steps for improving safety. The patient engagement report examines why it is important to involve people using services in improving safety and how this might best be done. -
Content ArticlePrescribing errors in general practice are an expensive, preventable cause of safety incidents, illness, hospitalisations and even deaths. Serious errors affect one in 550 prescription items, while hazardous prescribing in general practice contributes to around 1 in 25 hospital admissions. Outcomes of a trial published in the Lancet showed a reduction in error rates of up to 50% following adoption of PINCER. PINCER is a methodology for reducing medication errors and, thereby, improving medication safety. Using clinical audit tools alongside quality improvement methodology to review groups of patients taking high risk medicines/combinations of medicines, PINCER ensures that any risks are mitigated.
-
Content Article
How to investigate and manage a medication incident
Claire Cox posted an article in Medication
Of the nearly 237 million medication errors occurring in England each year, 28% have the potential to cause harm. This article published in The Pharmaceutical Journal outlines the immediate steps to be taken following identification of a medicines safety incident. -
Content ArticlePeople should not be given medicines without their knowledge if they have the mental capacity to make decisions about their treatment and care. This guide from the National Institute for Healthcare Excellence (NICE) and Social Care Institute for Excellence (SCIE) is aimed at care home managers or anyone providing medicines support in care homes.
-
Content ArticleThis study from Westbrooke et al. published in BMJ Quality and Safety evaluates the effectiveness of a ‘Do not interrupt’ bundled intervention to reduce non-medication-related interruptions to nurses during medication administration.
-
Content Article
Pills: Reviewing medication in care homes
Claire Cox posted an article in Patient medication stories
This film, by the Health Foundation, tells the story of how the well-being of older care home residents is enhanced by making sure they are only prescribed the medicine they really need, and the positive impact this has had on the people who work on the project too. -
Content ArticleSeveral factors contribute to medication errors in clinical practice settings, including the design of medication labels. The objective of this study from Estock et al., published in the Journal of Patient Safety, was to quantify the impact of label design on medication safety in a realistic, high-stress clinical situation.
-
Content ArticleEveryone, including patients and health care professionals, has a role to play in ensuring medication safety. This video is part of WHO’s campaign to reduce medication-related harm by improving practices and reducing medication errors.
-
Content Article
NICE's Drug allergy overview (January 2019)
Claire Cox posted an article in Adverse interactions
This National Institute for Health and Care Excellence (NICE) Pathway describes in an interactive flowchart the process of what to do next if someone has a possible drug allergy/reaction. -
Content ArticleThe Black Country Partnership NHS Foundation Trust's medication error policy and pathway describes the procedure that must be followed when a medication error occurs.
